KORU Medical Systems Future Growth
Future criteria checks 1/6
KORU Medical Systems is forecast to grow earnings and revenue by 67.4% and 14.7% per annum respectively while EPS is expected to grow by 68% per annum.
Key information
67.4%
Earnings growth rate
68.0%
EPS growth rate
Medical Equipment earnings growth | 17.0% |
Revenue growth rate | 14.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Dec 2024 |
Recent future growth updates
Recent updates
KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10
Nov 16Impressive Turnaround At KORU Medical
Nov 06We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow
Aug 29KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares
Jul 30Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues
Feb 15We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely
Sep 21Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower
Jul 14We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate
Sep 27Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans
Oct 27Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report
Aug 14Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?
Feb 22Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture
Jan 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 44 | -1 | 0 | 1 | 3 |
12/31/2025 | 38 | -4 | -1 | 0 | 5 |
12/31/2024 | 33 | -6 | -3 | -1 | 5 |
9/30/2024 | 32 | -12 | -2 | 0 | N/A |
6/30/2024 | 31 | -12 | -1 | 0 | N/A |
3/31/2024 | 29 | -13 | -1 | -1 | N/A |
12/31/2023 | 29 | -14 | -6 | -5 | N/A |
9/30/2023 | 29 | -8 | -5 | -5 | N/A |
6/30/2023 | 29 | -8 | -7 | -6 | N/A |
3/31/2023 | 29 | -9 | -11 | -8 | N/A |
12/31/2022 | 28 | -9 | -8 | -5 | N/A |
9/30/2022 | 27 | -8 | -10 | -7 | N/A |
6/30/2022 | 25 | -8 | -8 | -6 | N/A |
3/31/2022 | 24 | -6 | -4 | -3 | N/A |
12/31/2021 | 23 | -5 | -5 | -4 | N/A |
9/30/2021 | 21 | -4 | -6 | -5 | N/A |
6/30/2021 | 21 | -3 | -7 | -6 | N/A |
3/31/2021 | 23 | -3 | -4 | -4 | N/A |
12/31/2020 | 24 | -1 | -2 | -1 | N/A |
9/30/2020 | 26 | 0 | 1 | 2 | N/A |
6/30/2020 | 27 | 0 | 4 | 5 | N/A |
3/31/2020 | 25 | 1 | 1 | 2 | N/A |
12/31/2019 | 23 | 1 | 0 | 0 | N/A |
9/30/2019 | 21 | 0 | -1 | 0 | N/A |
6/30/2019 | 19 | 0 | -1 | -1 | N/A |
3/31/2019 | 18 | 0 | 0 | 0 | N/A |
12/31/2018 | 17 | 1 | 1 | 1 | N/A |
9/30/2018 | 18 | 2 | 2 | 2 | N/A |
6/30/2018 | 17 | 2 | N/A | 2 | N/A |
3/31/2018 | 16 | 1 | N/A | 1 | N/A |
12/31/2017 | 16 | 1 | N/A | 1 | N/A |
2/28/2017 | 12 | -1 | N/A | 0 | N/A |
11/30/2016 | 13 | 0 | N/A | 1 | N/A |
8/31/2016 | 13 | 0 | N/A | 1 | N/A |
5/31/2016 | 13 | 1 | N/A | 2 | N/A |
2/29/2016 | 12 | 1 | N/A | 2 | N/A |
11/30/2015 | 12 | 1 | N/A | 1 | N/A |
8/31/2015 | 12 | 1 | N/A | 1 | N/A |
5/31/2015 | 11 | 1 | N/A | 1 | N/A |
2/28/2015 | 11 | 1 | N/A | 1 | N/A |
11/30/2014 | 10 | 1 | N/A | 1 | N/A |
8/31/2014 | 10 | 1 | N/A | 1 | N/A |
5/31/2014 | 9 | 1 | N/A | 1 | N/A |
2/28/2014 | 9 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KRMD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KRMD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KRMD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KRMD's revenue (14.7% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: KRMD's revenue (14.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KRMD's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 00:10 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KORU Medical Systems, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Neil Chatterji | B. Riley Securities, Inc. |
Kyle Bauser | B. Riley Securities, Inc. |
Kyle Rose | Canaccord Genuity |